Pancreatic Cancer Research

ResearcherDuke Medical CenterNo recent work listed

Andrew S. Barbas

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3476-2313; OpenAlex author ID A5047595470. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper

Papers 3

  1. The Synergistic Role of Irreversible Electroporation and Chemotherapy for Locally Advanced Pancreatic Cancer. Co-author DOI 10.3389/fonc.2022.843769↗
  2. Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians. Last author DOI 10.3390/cancers13051071↗
  3. Comparison of outcomes and the use of multimodality therapy in young and elderly people undergoing surgical resection of pancreatic cancer. Co-author DOI 10.1111/j.1532-5415.2011.03785.x↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Dimitrios Moris · 2 shared papers, 2021–2022 · strength 0.45
  2. Argyrios Gyftopoulos · 1 shared paper, 2022 · strength 0.22
  3. Ioannis A. Ziogas · 1 shared paper, 2022 · strength 0.22
  4. Dimitrios Giannis · 1 shared paper, 2021 · strength 0.22
  5. Sandhya A. Lagoo · 1 shared paper, 2012 · strength 0.03
  6. Dan German Blazer · 1 shared paper, 2012 · strength 0.03
  7. Eugene P. Ceppa · 1 shared paper, 2012 · strength 0.03
  8. Rebekah Ruth White · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.